Tumor scintigraphy by the method for subtracting the initial image with technetium-99m labeled antibody

Citation
Y. Karube et al., Tumor scintigraphy by the method for subtracting the initial image with technetium-99m labeled antibody, ANN NUCL M, 13(6), 1999, pp. 407-413
Citations number
29
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
ANNALS OF NUCLEAR MEDICINE
ISSN journal
09147187 → ACNP
Volume
13
Issue
6
Year of publication
1999
Pages
407 - 413
Database
ISI
SICI code
0914-7187(199912)13:6<407:TSBTMF>2.0.ZU;2-7
Abstract
The method for subtracting the initial image from the localization image wa s evaluated for radioimmunoscintigraphy of tumors with technetium-99m (Tc-9 9m) labeled antibodies. Monoclonal antibodies were parental mouse and mouse -human chimeric antibodies to carcinoembryonic antigen (CEA), designated F1 1-39 and ChF11-39, respectively, both of which have been found to discrimin ate CEA in tumor tissues from the CEA-related antigens. After reduction of the intrinsic disulfide bonds, these antibodies were labeled with Tc-99m. I n vivo studies were performed on athymic nude mice bearing the human CEA-pr oducing gastric carcinoma xenografts. Though biodistribution results showed selective and progressive accumulation of Tc-99m labeled antibodies at the tumor site, high radioactivity in blood was inappropriate for scintigraphi c visualization of the tumors within a few hours. We examined the subtracti on of the initial Tc-99m image from the Tc-99m localization image after a f ew hours. Subtracted images of the same count reflected the in vivo behavio r of the Tc-99m radioactivity. The subtracted scintigrams revealed excellen t tumor images with no significant extrarenal background. Visualization of the tumor site was dependent on antigen-specific binding and nonspecific ex udation. These results demonstrate that a method of subtraction of the init ial image may serve as a potentially useful diagnostic method for an abnorm al site for agents with a low pharmacokinetic value.